ID

37923

Descripción

Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01230970

Link

https://clinicaltrials.gov/show/NCT01230970

Palabras clave

Versiones (1)
  1. 30/8/19 30/8/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

30 de agosto de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT01230970

Inglés

Eligibility Breast Cancer NCT01230970

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
female subjects 55 to 80 years with histologically or cytologically documented primary intraductal or lobular invasive breast cancer that meets the following criteria:
Descripción

Gender | Age | Intraductal breast neoplasm Invasive | Invasive Lobular Breast Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
UMLS CUI [3,1]
C0948967
UMLS CUI [3,2]
C0205281
UMLS CUI [4]
C0279565
t2, n0 or n1, m0.
Descripción

TNM Breast tumor staging

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0474926
primary tumour clinically determined to be 2 to 5 cm in the greatest dimension.
Descripción

Tumor size, largest dimension

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1272779
laboratory documentation of positive oestrogen receptor (er+) status in at least 10% of the tumour cells.
Descripción

Neoplastic Cells Percentage Estrogen receptor positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0597032
UMLS CUI [1,2]
C0439165
UMLS CUI [1,3]
C0279754
laboratory documentation of her-2 negative status.
Descripción

HER2 Negative

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348908
postmenopausal defined as
Descripción

Postmenopausal state

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232970
no spontaneous menses for a total of 2 years
Descripción

Absence Menses Spontaneous Duration

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0025344
UMLS CUI [1,3]
C0205359
UMLS CUI [1,4]
C0449238
amenorrheic for at least 12 months with serum oestrogen level <30 pg/ml, and both luteinising hormone (lh)/follicle stimulating hormone (fsh) >20 iu/l, chemotherapy-induced amenorrhoea for at least 12 months
Descripción

Amenorrhea Duration | Total serum estrogen measurement | Luteinizing hormone measurement | Follicle stimulating hormone measurement | Amenorrhea Chemotherapy Induced

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0002453
UMLS CUI [1,2]
C0449238
UMLS CUI [2]
C2041290
UMLS CUI [3]
C0202123
UMLS CUI [4]
C0202022
UMLS CUI [5,1]
C0002453
UMLS CUI [5,2]
C3665472
UMLS CUI [5,3]
C0205263
bilateral oophorectomy, or radiation castration and amenorrhoeic for at least 3 months.
Descripción

Bilateral oophorectomy | Radiation castration | Amenorrhea Duration

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278321
UMLS CUI [2]
C0877129
UMLS CUI [3,1]
C0002453
UMLS CUI [3,2]
C0449238
eastern cooperative oncology group (ecog) performance status ≤2.
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
has locally advanced breast cancer that is considered non-operable without neoadjuvant therapy.
Descripción

Locally advanced breast cancer Inoperable | Neoadjuvant Therapy Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3495949
UMLS CUI [1,2]
C0205187
UMLS CUI [2,1]
C0600558
UMLS CUI [2,2]
C0332197
has evidence of metastatic disease
Descripción

Neoplasm Metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027627
as a diagnosis of inflammatory breast cancer
Descripción

Inflammatory Breast Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278601
has ductal carcinoma in situ
Descripción

DCIS

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007124
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT01230970

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age | Intraductal breast neoplasm Invasive | Invasive Lobular Breast Carcinoma
Item
female subjects 55 to 80 years with histologically or cytologically documented primary intraductal or lobular invasive breast cancer that meets the following criteria:
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0948967 (UMLS CUI [3,1])
C0205281 (UMLS CUI [3,2])
C0279565 (UMLS CUI [4])
TNM Breast tumor staging
Item
t2, n0 or n1, m0.
boolean
C0474926 (UMLS CUI [1])
Tumor size, largest dimension
Item
primary tumour clinically determined to be 2 to 5 cm in the greatest dimension.
boolean
C1272779 (UMLS CUI [1])
Neoplastic Cells Percentage Estrogen receptor positive
Item
laboratory documentation of positive oestrogen receptor (er+) status in at least 10% of the tumour cells.
boolean
C0597032 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0279754 (UMLS CUI [1,3])
HER2 Negative
Item
laboratory documentation of her-2 negative status.
boolean
C2348908 (UMLS CUI [1])
Postmenopausal state
Item
postmenopausal defined as
boolean
C0232970 (UMLS CUI [1])
Absence Menses Spontaneous Duration
Item
no spontaneous menses for a total of 2 years
boolean
C0332197 (UMLS CUI [1,1])
C0025344 (UMLS CUI [1,2])
C0205359 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,4])
Amenorrhea Duration | Total serum estrogen measurement | Luteinizing hormone measurement | Follicle stimulating hormone measurement | Amenorrhea Chemotherapy Induced
Item
amenorrheic for at least 12 months with serum oestrogen level <30 pg/ml, and both luteinising hormone (lh)/follicle stimulating hormone (fsh) >20 iu/l, chemotherapy-induced amenorrhoea for at least 12 months
boolean
C0002453 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C2041290 (UMLS CUI [2])
C0202123 (UMLS CUI [3])
C0202022 (UMLS CUI [4])
C0002453 (UMLS CUI [5,1])
C3665472 (UMLS CUI [5,2])
C0205263 (UMLS CUI [5,3])
Bilateral oophorectomy | Radiation castration | Amenorrhea Duration
Item
bilateral oophorectomy, or radiation castration and amenorrhoeic for at least 3 months.
boolean
C0278321 (UMLS CUI [1])
C0877129 (UMLS CUI [2])
C0002453 (UMLS CUI [3,1])
C0449238 (UMLS CUI [3,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status ≤2.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Locally advanced breast cancer Inoperable | Neoadjuvant Therapy Absent
Item
has locally advanced breast cancer that is considered non-operable without neoadjuvant therapy.
boolean
C3495949 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C0600558 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Neoplasm Metastasis
Item
has evidence of metastatic disease
boolean
C0027627 (UMLS CUI [1])
Inflammatory Breast Carcinoma
Item
as a diagnosis of inflammatory breast cancer
boolean
C0278601 (UMLS CUI [1])
DCIS
Item
has ductal carcinoma in situ
boolean
C0007124 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial